Example: Heart Attack

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Total 9779 results

NCT01941004

Withdrawn

Safety and Efficacy of Fingolimod in MS Patients in China

Multiple Sclerosis (Relapsing Remitting)
NCT02221271

Completed

Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome

Guillain-Barré Syndrome
NCT02222948

Terminated

Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis (EMPIRE)

Relapsing-remitting Multiple Sclerosis
NCT01718392

Completed

Rehabilitation in Multiple Sclerosis: Influence of Exercise on Development of Insulin Resistance, Muscle Power and Aerobic Capacity

Multiple Sclerosis
NCT01310166

Completed

Biomarker Study After Initiation of Treatment With Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis (Biobank)

Relapsing-remitting Multiple Sclerosis
NCT01914016

Completed

Functional Electrical Stimulation for People With Multiple Sclerosis Who Experience Foot Drop

Multiple Sclerosis
NCT01742052

Completed

Dose-finding Study of MT-1303

Relapsing-remitting Multiple Sclerosis
NCT02159573

Completed

Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab) (STRATEGY)

Relapsing-Remitting Multiple Sclerosis
NCT01659593

Unknown

Evaluation of the Efficiency of a Cognitive Remedial Program (PROCOG-SEP) Designed for Multiple Sclerosis Patients (PROCOG-SEP)

Multiple Sclerosis | Cognitive Disorders
NCT01874145

Completed

Safety and Tolerability of Glatiramer Acetate (GLACIER)

Relapsing-Remitting Multiple Sclerosis
NCT00902135

Completed

Injection Management With Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH)

Relapsing-Remitting Multiple Sclerosis
NCT01264848

Completed

Endovascular Treatment for Chronic Cerebrospinal Venous Insufficiency (CCSVI)

Multiple Sclerosis
NCT00451451

Completed

Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis (CONFIRM)

Relapsing-Remitting Multiple Sclerosis
NCT02301650

Unknown

The Effect of Anti-viral Drugs Used in Late Pregnancy on Long-term Development of Children

the Safety of Anti-viral Drugs Used in Late Pregnancy
NCT01709812

Withdrawn

Effect of an Individualized Patient Support Program on Treatment Satisfaction in Fingolimod-treated Patients With RRMS (STAY)

Relapsing-remitting Multiple Sclerosis
NCT02029378

Unknown

Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome Study (ICA-GBS)

Gullian Barre Syndrome
NCT01142453

Completed

An Observational Study Evaluating Therapy Optimisation Using High-frequency and High-dosage Administration of Interferon-beta (Rebif®) in Multiple Sclerosis (MS) Patients

Relapsing-Remitting Multiple Sclerosis
NCT00818038

Completed

A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function (TRUST)

Relapsing-Remitting Multiple Sclerosis
NCT01578785

Terminated

An Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) (GLOW)

Relapsing-Remitting Multiple Sclerosis
NCT00904826

Completed

An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica

Neuromyelitis Optica | Devic's Disease
NCT00493116

Completed

Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta (RENeu)

Relapsing-Remitting Multiple Sclerosis
NCT00168766

Completed

Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS

Relapsing-remitting Multiple Sclerosis
NCT00391079

Completed

Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS

Multiple Sclerosis
NCT00291148

Completed

Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Management of MS-induced Neuropathic Pain

Multiple Sclerosis | Neuropathic Pain
NCT00498199

Terminated

Visual Impairment, Oscillopsia and Multiple Sclerosis

Multiple Sclerosis
NCT00360906

Completed

Omega-3 Fatty Acid Treatment in Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis
NCT00219908

Terminated

Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis
NCT07451600

Recruiting

Effectiveness of TMS on Spasticity and Balance for Patients With MS

Multiple Sclerosis
NCT07225504

Recruiting

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis (REMASTER)

Secondary Progressive Multiple Sclerosis (SPMS)
NCT07154524

Recruiting

Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (IFTOC)

Chronic Inflammatory Demyelinating Polyneuropathy
NCT07029867

Not yet recruiting

Efficacy and Safety of Yishen Daluo Yin Granule for Relapsing-Remitting Multiple Sclerosis

Relapse Remitting Multiple Sclerosis
NCT06775704

Recruiting

Clinical and Radiological Outcomes of the ROMAX Hip Resurfacing System

Hip Dysplasia, Congenital | Arthritis (Hip)
NCT06700343

Recruiting

Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

Relapsing-remitting Multiple Sclerosis (RRMS)
NCT06653985

Recruiting

Intra-articular Corticosteroid With Hyaluronic Acid Plus Physiotherapy for Hip Pathologies (NON-OP HIP) (NON-OP HIP)

Osteoarthritis | Femoroacetabular Impingement Syndrome | Labrum Injury of the Hip Joint
NCT06627374

Recruiting

Study of Thoracic Ultrasound As a Response to the Closure of Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants (LUNG PDA)

Patency of the Ductus Arteriosus
NCT06618872

Recruiting

Incremental Diagnostic Value of Tau-PET With [18F]RO948 vs Amyloid-PET in Patients With Cognitive Impairment (IDV of tau-PET)

Dementia | Alzheimer Disease
NCT06297590

Recruiting

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

Alzheimer Disease
NCT06017726

Not yet recruiting

Insulin Resistance in Egyptian Patients With Multiple Sclerosis (IR-MS)

Multiple Sclerosis | Insulin Resistance
NCT05267275

Recruiting

Extended Resection for Rectal Cancer With Neoadjuvant Radiotherapy

the Incidence of Complications Related to Rectal Anastomosis After Neoadjuvant Therapy
NCT03586986

Recruiting

Risk Factors in Early Multiple Sclerosis (RISEMS)

Multiple Sclerosis | Clinically Isolated Syndrome | Biomarkers | Magnetic Resonance Imaging | Radiologically Isolated Syndrome
NCT07501520

Completed

Effect of Low Histamine-Based Modified Mediterranean Diet in Multiple Sclerosis (HistaMed-MS)

Mediterranean Diet | Multiple Sclerosis (MS) - Relapsing-remitting
NCT04377555

Completed

Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab

Multiple Sclerosis, Relapsing
NCT02003924

Completed

Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer (PROSPER)

Prostate Cancer | Cancer of the Prostate | Nonmetastatic Castration-Resistant Prostate Cancer
NCT05998616

Completed

Feasibility of Remote Exercise Training for Hispanics/Latinos With MS (FERLAMS)

Multiple Sclerosis
NCT07188844

Enrolling by invitation

An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Chronic Inflammatory Demyelinating Polyneuropathy
NCT07041229

Enrolling by invitation

Comparison of Methods for Removing Large Benign Broad-based Epithelial Neoplasms of the Colon: ESD and EMR. (ESDEMR)

Benign Colon Tumors
NCT04602390

Completed

Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis (MoveS-it)

Relapsing Remitting Multiple Sclerosis | Multiple Sclerosis (MS)
NCT02975349

Terminated

A Study of Efficacy and Safety of M2951 in Participants With Relapsing Multiple Sclerosis

Relapsing-remitting Multiple Sclerosis
NCT03193866

Completed

COMparison Between All immunoTherapies for Multiple Sclerosis. (COMBAT-MS)

Relapsing-remitting Multiple Sclerosis
NCT04997148

Completed

Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)

Relapsing-Remitting Multiple Sclerosis

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations